of Shareholders
MEETING DATE
RECONCILED · MIXED
Reconciled against the company’s Form 8-K Item 5.07 filed 2026-06-15.
ITEM-BY-ITEM RECOMMENDATIONS
The filing states five director nominees were nominated and no nominee is expected to be unavailable.
The audit committee stated Enrome had no relationship with the Company other than the usual auditor-client relationship.
The filing states the increase would provide shares for future financings and preserve authorized shares after any reverse stock split.
The filing states additional Series A shares would significantly dilute common stockholders’ voting power and further concentrate control in Ms. Yan.
Search company, ticker, executive, director or issue